Terms: = Breast cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Diagnosis
7 results:
1. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
[TBL] [Abstract] [Full Text] [Related]
2. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
[TBL] [Abstract] [Full Text] [Related]
3. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human breast cancer.
Khan K; Safi S; Abbas A; Badshah Y; Dilshad E; Rafiq M; Zahra K; Shabbir M
Biomed Res Int; 2020; 2020():1354381. PubMed ID: 33490232
[TBL] [Abstract] [Full Text] [Related]
4. klf4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.
Ma Y; Wu L; Liu X; Xu Y; Shi W; Liang Y; Yao L; Zheng J; Zhang J
Oncol Rep; 2017 Aug; 38(2):975-984. PubMed ID: 28656310
[TBL] [Abstract] [Full Text] [Related]
5. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
[TBL] [Abstract] [Full Text] [Related]
6. FBXO32 suppresses breast cancer tumorigenesis through targeting klf4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract] [Full Text] [Related]
7. Cadherins: The Superfamily Critically Involved in breast cancer.
Ashaie MA; Chowdhury EH
Curr Pharm Des; 2016; 22(5):616-38. PubMed ID: 26825466
[TBL] [Abstract] [Full Text] [Related]
